Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AbbVie Inc.ABBV · Entity 2800 | Director | May 08, 2026 | May 12, 2026 |
| NOV Inc.NOV · Entity 3662 | Director | May 24, 2022 | May 26, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AbbVie Inc.
Report date May 08, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 17,616 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Grant · Acquired 1,118 · Balance 17,616 F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). |
Filing footnotes · ownership attribution and instrument terms
F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
NOV Inc.
Report date May 24, 2022 · Filed May 26, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,402 |
Reported balance
After 2022-05-24 transaction · row 1
1 source rowRow 1 · 2022-05-24 · Grant · Acquired 8,473 · Balance 43,402 F1: An equity award of time-based restricted stock units pursuant to the NOV Inc. Long-Term Incentive Plan, which will vest on the first anniversary of the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: An equity award of time-based restricted stock units pursuant to the NOV Inc. Long-Term Incentive Plan, which will vest on the first anniversary of the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2026 Filed May 12, 2026 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001706126-26-000002 · form4-05122026_050513.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,616 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:05 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012798 · form4-05132025_050513.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,498 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 03, 2024 Filed May 7, 2024 22:30 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012522 · form4-05072024_060511.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,295 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 05, 2023 Filed May 9, 2023 21:03 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007673 · form4-05092023_090514.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,973 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:56 UTC | NOV Inc. NOV · Entity 3662 | GrantCommon Stock | 8,473 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-019744 · doc4.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,402 F1 · shares: An equity award of time-based restricted stock units pursuant to the NOV Inc. Long-Term Incentive Plan, which will vest on the first anniversary of the date of the grant. Read SEC document |
| May 06, 2022 Filed May 9, 2022 21:13 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002929 · edgar.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,523 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:32 UTC | NOV Inc. NOV · Entity 3662 | GrantCommon Stock | 9,819 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-020217 · doc4.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,929 Read SEC document |
| May 07, 2021 Filed May 11, 2021 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005205 · edgar.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,102 F1 · shares: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 20, 2020 Filed May 21, 2020 21:55 UTC | NOV Inc. NOV · Entity 3662 | GrantCommon Stock | 12,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-013904 · doc4.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,110 Read SEC document |
| May 08, 2020 Filed May 12, 2020 21:02 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 2,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-005784 · edgar.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,421 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 28, 2019 Filed May 29, 2019 21:58 UTC | NOV Inc. NOV · Entity 3662 | GrantCommon Stock | 8,219 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-015057 · doc4.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,648 Read SEC document |
| May 03, 2019 Filed May 7, 2019 20:53 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 2,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005671 · edgar.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,088 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 11, 2018 Filed May 14, 2018 21:13 UTC | NOV Inc. NOV · Entity 3662 | GrantCommon Stock | 4,429 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012738 · doc4.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,429 Read SEC document |
| May 04, 2018 Filed May 8, 2018 00:27 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 1,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006408 · edgar.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,669 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 05, 2017 Filed May 9, 2017 21:22 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 2,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006928 · edgar.xml · nonDerivative · entry 1 MEYER MELODY B · CIK 0001706126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,770 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.